Sterling Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Sterling Capital Management's MDGL Position: Q3 2026 in Review
Sterling Capital Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 8.7% in Q3 2026, selling an estimated $13.2K and leaving 264 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1307.
Sterling Capital Management first reported a position in MDGL in Q3 2024 and has held it in 9 quarters since. The position peaked at $155K in Q2 2026. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Sterling Capital Management held 264 shares of Madrigal Pharmaceuticals worth $133K as of Q3 2026.
- Sterling Capital Management sold 25 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $13.2K.
- Madrigal Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1307 holding.
- Sterling Capital Management first reported a position in Madrigal Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- Sterling Capital Management's Madrigal Pharmaceuticals position peaked at $155K in Q2 2026.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.